Astal Laboratories Financial Statements
Astal Laboratories financial statements. In FY2026, Astal Laboratories (ASTALLTD) reported revenue ₹134 Cr, net profit ₹8 Cr and EPS ₹2.04, with a net profit margin of 6.0% and ROE of 2.4%. Full financial statements from FY2025 to FY2026 (2 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Analyse ASTALLTD FII DII holdings to track promoter, FII and institutional holdings.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
ASTALLTD Revenue, Net Profit & EBITDA — Year-on-Year Growth
ASTALLTD YoY (Mar 2025 vs Mar 2026) — revenue +458.3%, net profit +166.7%, EBITDA +150.0%, expenses +552.6%. Read Astal Laboratories dividend policy for the complete payout history and dividend yield track record.
ASTALLTD Income Statement — Revenue, EBITDA & Net Profit
Astal Laboratories revenue ₹134 Cr, EBITDA ₹10 Cr, net profit ₹8 Cr, EPS ₹2.04 (2026) — net profit margin 6.0%. For live price, earnings ratios and company overview, see ASTALLTD screener.
| Particulars | Mar 2026 | Jun 2026 | Mar 2025 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 134 | 101 | 24 | 52 |
| Expenses | 124 | 89 | 19 | 49 |
| EBITDA | 10 | 12 | 4 | 4 |
| Operating Profit Margin % | 8.00% | 12.00% | 18.00% | 7.00% |
| Depreciation | 1 | 1 | 0 | 0 |
| Interest | 1 | 1 | 0 | 0 |
| Profit Before Tax | 8 | 10 | 4 | 3 |
| Tax | 1 | 1 | 1 | 1 |
| Net Profit | 8 | 9 | 3 | 2 |
| Earnings Per Share (₹) | 2.04 | 2.19 | 2.80 | 2.19 |
ASTALLTD Balance Sheet — Assets, Liabilities & Shareholders' Equity
ASTALLTD total assets ₹519 Cr, total equity ₹334 Cr, total liabilities ₹ Cr (2026) — ROE 2.4%.
| Particulars | 2026 | 2025 |
|---|---|---|
| ASSETS | ||
| Total Assets | 519 | 63 |
| Current Assets | 243 | 46 |
| Fixed Assets | 65 | 11 |
| Capital Work in Progress | 0 | 0 |
| Investments | 203 | 0 |
| Other Assets | 251 | 52 |
| LIABILITIES | ||
| Total Liabilities | ||
| Current Liabilities | 20 | 1 |
| Non-Current Liabilities | ||
| SHAREHOLDERS' EQUITY | ||
| Total Equity | 334 | 36 |
| Share Capital | 42 | 10 |
| Reserves & Surplus | 290 | 22 |
ASTALLTD Cash Flow Statement — Operating, Investing & Financing
Astal Laboratories operating cash flow ₹-18 Cr, investing ₹-2 Cr, financing ₹3 Cr, net cash flow ₹-17 Cr (2026).
| Particulars | March 2026 | March 2025 |
|---|---|---|
| Operating Activities | -18 | -13 |
| Investing Activities | -2 | -8 |
| Financing Activities | 3 | 3 |
| Net Cash Flow | -17 | -17 |